In this note McKinsey & Company offer its latest insights on the COVID-19 pandemic, starting with a survey of the current epidemiology and the five dynamics leaders need to watch: the efficacy of the surge in critical care, the expansion of testing and other traditional approaches, the development of antibody testing, the unknown nature of immunity, and a wave of innovation that might produce treatments and vaccines.
They then highlight four other recently published articles, each designed to help senior executives think through the challenges of restarting economies.
Leave a Comment
You must be logged in to post a comment.